racemetirosine has been researched along with Dystonia in 7 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We therefore treated patients having various forms of dystonia and chorea with tetrabenazine (TBZ), and then added AMPT to determine if further improvement could be obtained." | 7.66 | Alpha methylparatyrosine and tetrabenazine in movement disorders. ( Lang, AE; Marsden, CD, 1982) |
| " We therefore treated patients having various forms of dystonia and chorea with tetrabenazine (TBZ), and then added AMPT to determine if further improvement could be obtained." | 3.66 | Alpha methylparatyrosine and tetrabenazine in movement disorders. ( Lang, AE; Marsden, CD, 1982) |
| "Acute dystonia can also be reliably induced in many primate species by neuroleptic treatment with comparable time course, symptomatology and pharmacological characteristics to those observed in man." | 2.37 | Acute dystonia induced by neuroleptic drugs. ( Jenner, P; Marsden, CD; Rupniak, NM, 1986) |
| "He had a negative evaluation for malignant hyperthermia (MH), and we suggest that NMS differs from MH." | 1.26 | Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. ( Burke, RE; Fahn, S; Louis, K; Mayeux, R; Weinberg, H; Willner, JH, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ankenman, R | 1 |
| Salvatore, MF | 1 |
| Burke, RE | 1 |
| Fahn, S | 1 |
| Mayeux, R | 1 |
| Weinberg, H | 1 |
| Louis, K | 1 |
| Willner, JH | 1 |
| Lang, AE | 1 |
| Marsden, CD | 2 |
| McCann, UD | 1 |
| Penetar, DM | 1 |
| Belenky, G | 1 |
| Jacquet, Y | 1 |
| Rupniak, NM | 1 |
| Jenner, P | 1 |
| McKeon, TW | 1 |
| Lorden, JF | 1 |
| Beales, M | 1 |
| Oltmans, GA | 1 |
1 review available for racemetirosine and Dystonia
| Article | Year |
|---|---|
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease M | 1986 |
6 other studies available for racemetirosine and Dystonia
| Article | Year |
|---|---|
Low dose alpha-methyl-para-tyrosine (AMPT) in the treatment of dystonia and dyskinesia.
Topics: Adolescent; Adult; alpha-Methyltyrosine; Brain Injuries; Dopamine; Dyskinesia, Drug-Induced; Dystoni | 2007 |
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.
Topics: Adolescent; Adult; alpha-Methyltyrosine; Antipsychotic Agents; Child; Dopamine; Dystonia; Female; Fe | 1981 |
Alpha methylparatyrosine and tetrabenazine in movement disorders.
Topics: Adult; alpha-Methyltyrosine; Chorea; Drug Therapy, Combination; Dystonia; Female; Humans; Male; Meth | 1982 |
Acute dystonic reaction in normal humans caused by catecholamine depletion.
Topics: Acute Disease; Adolescent; Adult; alpha-Methyltyrosine; Dystonia; Humans; Male; Methyltyrosines; Tyr | 1990 |
A dystonia-like syndrome after neuropeptide (MSH/ACTH) stimulation of the rat locus ceruleus.
Topics: Adrenocorticotropic Hormone; alpha-Methyltyrosine; Animals; Dose-Response Relationship, Drug; Dyston | 1988 |
Alterations in the noradrenergic projection to the cerebellum of the dystonic (dt) rat.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Cerebellum; Dystonia; Female; Male; Methoxyhydroxyphenyl | 1986 |